On July 17th, Emmes India team and our global leaders celebrated the official inauguration of Emmes India’s second office in Bangalore. Led by Rama Kondru, CEO, Veridix AI and Archana Sarda, Managing Director, this milestone represents our commitment to growth and excellence. A heartfelt thank you to our entire leadership team for their invaluable presence and support. Your vision and guidance have been pivotal in achieving this accomplishment. And we take this opportunity to thank all our employees for the hard work and dedication. Here's to new beginnings, collaborative success, and endless opportunities! 🚀 Sastry Chilukuri, Rama Kondru, Ph.D., Peter Ronco, Archana Sarda, Karunakar Reddy, Pankaj Dua, Arpit Choudhury Vineet Agrawal, Narasimha Rao Ayyalasomayajula, Rajaram Venkatesan, Sagar Sutar, Sandesh Nalawade Ph.D., MBA, PMP®, Subhrajit Ghose, Henry Lin, Scott Hospes
Emmes
Research Services
Rockville, MD 27,161 followers
The Industry’s First Native Digital and AI Specialty CRO
About us
For over 40 years, our team of 1,000 experienced professionals have provided the full range of Contract Research Organization expertise necessary to conduct clinical research with a firm scientific basis that is fully compliant with national and international regulatory guidelines. With offices throughout the US, Europe, Canada, and India, Emmes supports the advancement of global public health and biopharmaceutical innovation through disciplined science, rigorous research, fact-based decision-making, and operational excellence. Emmes possesses knowledge across a broad range of therapeutic areas, with specializations in Vaccines and Infectious Diseases, Ophthalmology, Immunology and Neuroscience. From comprehensive support of pandemic research to groundbreaking work in cell and gene therapy across the globe, Emmes has collaborated on clinical research across a wide array of disease states in over 75 nations. As a strategic collaborator with applied talent in over 2,000 clinical trials and contributions to over 2,500 publications that advance the understanding of medicine and public health, Emmes is committed to expanding the services offered to best meet the changing needs of clients and studies. Ongoing investments in global clinical research capabilities, innovative data management platforms, biostatistics/bioinformatics expertise, and people have enabled Emmes to provide a multi-faceted approach to help you meet your research objectives. Emmes is a diverse, inclusive, innovative CRO that values integrity, agility, passion for excellence, collaborative partnerships, and intellectual curiosity.
- Website
-
http://www.emmes.com
External link for Emmes
- Industry
- Research Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Rockville, MD
- Type
- Privately Held
Locations
Employees at Emmes
Updates
-
Emmes and our team of experts will be present at the Military Health System Research Symposium (MHSRS) 2024 at Booth #215, August 26-29. Visit our booth or schedule a meeting here:https://hubs.la/Q02HtpZq0 to learn about our clinical expertise and differentiated capabilities, including advanced data management, regulatory affairs, and biostatistical analysis that support military health research. Amberlie Ann Clutterbuck, PhD, Jessie Kennedy, MPH, Natalia de Val, Jeanine May, Angela Terhune Hargrove, and Victoria Coleman-Cowger will be representing Emmes at MHSRS and available to discuss collaboration opportunities as well as our critical care expertise. #Emmes #CRO #ClinicalTrials
-
-
Join Emmes at the Alzheimer's Association International Conference (AAIC) 2024 Conference at Booth #940 July 28- August 1. Our team of experts will be there to discuss how our innovative AI solutions tailored for complex neurodegenerative trials and Ai enabled excellence in CNS research and precision data collection can help support your trial. With over 180 CNS trials completed, we offer a combination of clinical expertise and innovative support for neurodegenerative trials to drive precision data collection, management and integrity with real-time insights for maximum results. Learn more at https://hubs.la/Q02G_3Fd0 Steffanie Wilson, PhD, Courtney Nelson-Douthit, Julia Hamilos, Victoria Coleman-Cowger, Stephanie H. Bagully, PhD, Matthew Donnelly, Alzheimer's Association® #AAIC2024 #AlzheimersResearch #CNSResearch #Emmes #CRO
-
-
We are excited to announce that outcomes from the NCI-AMC ANCHOR study, where Emmes served as the Data Management Center, has resulted in a revision of the Centers for Disease Control's guidelines for anal cancer screening & prevention. Click the link below to find out more. https://hubs.la/Q02GrK920
-
Join Emmes at the Military Health System Research Symposium (MHSRS) 2024 to meet our team of experts including Amberlie Ann Clutterbuck, PhD, Jessie K Kennedy, MPH, Natalia de Val, Jeanine May, Angela Terhune Hargrove, and Victoria Coleman-Cowger. We'll be discussing our collaboration opportunities and our experience critical care. Emmes offers clinical expertise and differentiated capabilities including advanced data management, regulatory affairs, and biostatistical analysis to support military health research through innovative solutions. Schedule a Meeting at MHSRS here: https://hubs.la/Q02G53Zp0
-
-
Download VaxTRIALS, part of Emmes Group, our sister company's eBook: https://hubs.la/Q02FfYcR0 for expert tips on navigating the complexities of regulatory and ethical approvals in vaccine trials. Leveraging their global footprint, local knowledge, and decades of clinical excellence, the eBook provides valuable strategies on expediting approvals, streamlining processes and more to help drive rapid and efficient trials. #VaccineTrials #ClinicalResearch #RegulatoryApprovals #CROpartner #ClinicalTrials
-
-
Engaging key study personnel early is crucial for aligning on study goals and ensuring efficient communication. Our sister company, VaxTRIALS, part of Emmes Group's proactive approach to feasibility exercises coupled with our tech-enabled solutions allows for rapid enrollment and seamless coordination, ensuring trials are quicker, flexible, and more cost-effective. Discover more strategies for streamlining your vaccine trials in our latest eBook: https://hubs.la/Q02DqqjL0 #VaccineTrials #ClinicalTrials #TrialEnrollement #StudyStartUp #CROpartner #ClinicalResearch
-
-
We are thrilled to announce that Amber Sapp, PT, DPT has been nominated for the RARE Champion in Research Award by Global Genes! At Emmes, we’re incredibly proud to see Amber’s dedication and passion for advancing rare disease research recognized with this prestigious nomination. Congratulations, Amber! "I am deeply honored and grateful to be nominated for the RARE Champion in Research Award by Global Genes. As someone passionate and dedicated to advancing research for rare diseases, this recognition is truly humbling and inspires me to continue this important work,” says Amber. Winners will be announced later this month. Stay tuned! #RAREChampion #GlobalGenes #RareDiseaseResearch #Emmes #CRO
-
-
Emmes' Kriszha S. shared her gratitude after speaking at #ASCEND2024: "I'm incredibly thankful for the opportunity to present a poster and presentation about the Angelman Syndrome Video Assessment (ASVA) and how the video assessment methodology can be adapted for Rett Syndrome. I'd like to thank the International Rett Syndrome Foundation for accepting my abstract and hosting such a wonderful event. I always enjoy the thoughtful discussion with families and showcasing the innovative work done by Emmes." Visit https://hubs.la/Q02Dhy4v0 to learn more. #EmmesEndpointSolutions #Emmes #CRO #ClinicalTrials #RareDisease
-
-
Read ET Pharma’s interview with Archana Sarda, Managing Director of Emmes India, where she discusses how AI is revolutionizing clinical trials, making them faster and smarter than ever before. Sarda discusses how, with the power of AI, we can enhance trial efficiency, improve data accuracy, and accelerate the development of new treatments. Additionally, she provides her thoughts on how by integrating AI-driven insights we can optimize trial designs and decision-making processes, ultimately bringing life-saving therapies to patients more swiftly. Click here to read her full interview: https://hubs.la/Q02D2Sc40 #ClinicalTrials #AI #HealthcareInnovation #Emmes #EmmesIndia
-